Galan Lithium Ltd reports developments tied to its lithium exploration and development business, including the Hombre Muerto West and Candelas lithium brine projects on the Hombre Muerto Salar in Argentina. Company updates center on HMW Phase 1 construction, nanofiltration and evaporation-pond infrastructure, planned lithium chloride concentrate production, and staged capacity growth.
Recurring news also covers capital-structure disclosures, shareholder voting matters, governance appointments, operating and financial results, and quarterly activity reporting. Additional updates address financing for project development, regulatory approvals and community commitments, and exploration tenure associated with the company’s lithium portfolio.
Galan Lithium (GLNLF) completed Phase 1 construction at Hombre Muerto West, finished electrical and mechanical testing, and will begin wet commissioning. A A$40.0m institutional placement at A$0.41/share was completed to fund a Phase 1 expansion from 4 ktpa LCE to 5.2 ktpa LCE. Circa 10,000 t LCE brine inventory is ready for processing; first lithium chloride concentrate targeted in H1 2026 and first shipment H2 2026. Closing cash A$40.7m with no debt. Board strengthened with a new non-executive director and company secretary. Phase 2 permits (21 ktpa LCE) are held for staged growth.
Galan Lithium (ticker GLNLF) reports Phase 1 construction at Hombre Muerto West (HMW) is complete and the project has moved into testing and commissioning. Initial lithium chloride concentrate production is targeted H1 2026 with first shipment H2 2026, and steady production planned at 4,000 tpa LCE.
The company holds circa 10,000 t LCE brine inventory in evaporation ponds and will commence works to expand to 5,200 tpa LCE, targeting uplift in H1 2027; Phase 2 permits cover 21 ktpa with staged growth to 60 ktpa.
Galan Lithium (GLNLF) reports Phase 1 construction at Hombre Muerto West is approximately 92% complete, with nanofiltration plant assembly progressing and >25 personnel mobilised on site.
The project will move to testing and commissioning in the short term, with first processed brine targeted in early Q2 2026 and first lithium chloride concentrate expected in H1 2026. Phase 1 is designed for a 5,200 tpa LCE rate and has substantial brine inventory in evaporation ponds to support initial processing.
Galan Lithium (OTC:GLNLF) reports the nanofiltration plant for Phase 1 was delivered to the Hombre Muerto West (HMW) site and on-site assembly has begun. Phase 1 construction is ~85% complete with sylvinite evaporation ponds finished.
The company holds about 9,500 t LCE of brine inventory in ponds. First processed brine is targeted for early Q2 2026 and first lithium chloride concentrate is targeted in H1 2026. Phase 1 expanded production rate aims for 5,200 tpa LCE.
Galan Lithium (ASX:GLNLF) received firm commitments for an institutional placement of A$40.0 million at A$0.41 per share and directors committed to a further A$1.0 million (subject to shareholder approval). Proceeds will fund a 30% expansion of Phase 1 HMW to 5.2 ktpa LCE, Greenbushes South exploration and working capital.
Phase 1 construction continues with first lithium chloride production targeted for H1 2026. Tranche 1 (~86.6M shares) settles in early February; Tranche 2 (13.4M shares) awaits EGM approval in mid-March 2026.
Galan Lithium (OTC:GLNLF) confirmed the appointment of Ofer Amir as a Non-Executive Director and Katherine Garvey as Company Secretary on 22 January 2026.
Mr Amir is founder of the Clean Elements Fund and brings European capital markets expertise to the board. Ms Garvey is a corporate lawyer with experience in resources-sector corporate and commercial matters, including capital raisings, finance, acquisitions and disposals, Corporations Act and ASX Listing Rule compliance, corporate governance and company secretarial duties. Ms Garvey replaces Mike Robbins, who served as company secretary since 2013 and was thanked for his contributions.
Galan Lithium (OTC:GLNLF) reports Phase 1 construction at Hombre Muerto West (HMW) is advancing toward first production in H1 2026. Phase 1 is designed for 4,000 tpa LCE with potential to expand above 5,000 tpa LCE. The nano-filtration plant was assembled, tested, containerised and dispatched for site delivery and commissioning in early 2026. Cash at 31 December 2025 was A$15 million, the company has no debt and an undrawn US$6 million prepayment facility. The A$20 million Clean Elements placement completed with two A$10 million tranches.
Galan Lithium (OTC:GLNLF) reports Phase 1 at Hombre Muerto West (HMW) remains on track toward first production in H1 2026. The nano-filtration plant was fully assembled and tested off-site in Sydney and is now in transit to South America for on-site commissioning in early 2026. Phase 1 is designed for 4,000 tpa LCE; evaporation ponds 4 and 5 were re‑designed, liners installed, and subdivisions begun to optimise lithium chloride concentration. Earthworks are complete, concrete foundations poured, and power, electrical systems and pumps have been ordered. The company is also evaluating an option to expand Phase 1 to ~5,400 tpa LCE as studied in the 2023 DFS.
Galan Lithium (OTC:GLNLF) confirmed early completion of a A$20 million placement from Clean Elements with the second A$10 million tranche received on 5 November 2025. The proceeds provide the final equity component to fund construction of Phase 1 of the Hombre Muerto West lithium brine project in Argentina, with first lithium chloride production remaining on track for H1 2026. Galan reports a strong balance sheet with no debt and the ability to draw a US$6 million Authium offtake prepayment facility, subject to conditions precedent. Clean Elements will gain a board seat with Ofer Amir appointed as Non-Executive Director before year-end.
Galan Lithium (OTC:GLNLF) reported Q3 2025 activity highlighting secured funding, regulatory approval and construction progress at Hombre Muerto West (HMW).
Key facts: a $20.0M placement with Clean Elements (Tranche 1 of $10.0M settled; Tranche 2 $10.0M due in November 2025), cash and liquid assets of ~$11.0M, RIGI approval (July 2025) granting fiscal incentives, and Phase 1 works advancing with pond design complete and nano-filtration fabrication underway (lab tests show 99% sulphate removal). The company says it is funded to complete Phase 1 and target first lithium chloride production in H1 2026.